222 related articles for article (PubMed ID: 9723886)
21. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
22. An estrogen-independent MCF-7 breast cancer cell line which contains a novel 80-kilodalton estrogen receptor-related protein.
Pink JJ; Jiang SY; Fritsch M; Jordan VC
Cancer Res; 1995 Jun; 55(12):2583-90. PubMed ID: 7780972
[TBL] [Abstract][Full Text] [Related]
23. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
[TBL] [Abstract][Full Text] [Related]
24. Effects of estrogen on leptin gene promoter activation in MCF-7 breast cancer and JEG-3 choriocarcinoma cells: selective regulation via estrogen receptors alpha and beta.
O'Neil JS; Burow ME; Green AE; McLachlan JA; Henson MC
Mol Cell Endocrinol; 2001 May; 176(1-2):67-75. PubMed ID: 11369444
[TBL] [Abstract][Full Text] [Related]
25. Proximal events in signaling by plasma membrane estrogen receptors.
Razandi M; Pedram A; Park ST; Levin ER
J Biol Chem; 2003 Jan; 278(4):2701-12. PubMed ID: 12421825
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
[TBL] [Abstract][Full Text] [Related]
27. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
28. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
29. Regulation of estrogen receptor-alpha gene expression by epidermal growth factor.
Stoica A; Saceda M; Doraiswamy VL; Coleman C; Martin MB
J Endocrinol; 2000 May; 165(2):371-8. PubMed ID: 10810301
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
Aronica SM; Katzenellenbogen BS
Mol Endocrinol; 1993 Jun; 7(6):743-52. PubMed ID: 7689695
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol.
Hung H
J Cell Physiol; 2004 Feb; 198(2):197-208. PubMed ID: 14603522
[TBL] [Abstract][Full Text] [Related]
32. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
33. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells.
Molis TM; Spriggs LL; Hill SM
Mol Endocrinol; 1994 Dec; 8(12):1681-90. PubMed ID: 7708056
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional repression of RORalpha activity in human breast cancer cells by melatonin.
Dai J; Ram PT; Yuan L; Spriggs LL; Hill SM
Mol Cell Endocrinol; 2001 May; 176(1-2):111-20. PubMed ID: 11369450
[TBL] [Abstract][Full Text] [Related]
35. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
[TBL] [Abstract][Full Text] [Related]
36. Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domain.
Bitonti AJ; Dumont JA; Salituro FG; McDonald IA; Jarvi ET; Frey LM; Wright PS; Baumann RJ
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):21-30. PubMed ID: 8809183
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
38. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells.
Oh AS; Lorant LA; Holloway JN; Miller DL; Kern FG; El-Ashry D
Mol Endocrinol; 2001 Aug; 15(8):1344-59. PubMed ID: 11463858
[TBL] [Abstract][Full Text] [Related]
39. Melatonin blocks the activation of estrogen receptor for DNA binding.
Rato AG; Pedrero JG; Martinez MA; del Rio B; Lazo PS; Ramos S
FASEB J; 1999 May; 13(8):857-68. PubMed ID: 10224229
[TBL] [Abstract][Full Text] [Related]
40. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
